Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 28.99B | 28.40B | 27.75B | 28.34B | 31.24B | 29.15B |
Gross Profit | 12.50B | 12.03B | 9.79B | 8.77B | 9.40B | 9.30B |
EBITDA | 11.41B | 8.23B | 7.17B | 5.65B | 4.75B | 5.55B |
Net Income | 9.51B | 6.64B | 4.92B | 3.68B | 3.03B | 4.16B |
Balance Sheet | ||||||
Total Assets | 98.08B | 90.44B | 75.54B | 67.01B | 67.25B | 68.27B |
Cash, Cash Equivalents and Short-Term Investments | 26.69B | 27.21B | 23.54B | 20.88B | 20.43B | 26.02B |
Total Debt | 6.08B | 6.05B | 6.05B | 5.96B | 5.36B | 5.50B |
Total Liabilities | 22.89B | 20.72B | 18.33B | 17.88B | 16.20B | 15.54B |
Stockholders Equity | 73.24B | 67.86B | 55.91B | 48.10B | 50.32B | 52.24B |
Cash Flow | ||||||
Free Cash Flow | 10.11B | 9.24B | 6.17B | 6.43B | 2.48B | 4.38B |
Operating Cash Flow | 10.11B | 10.28B | 7.34B | 7.48B | 5.24B | 4.88B |
Investing Cash Flow | -4.54B | -6.82B | -1.86B | -1.45B | -6.00B | -14.21B |
Financing Cash Flow | -3.76B | -3.83B | -1.54B | -3.42B | -3.71B | 5.29B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
76 Outperform | $29.34B | 22.72 | 14.37% | 0.92% | 4.59% | 83.27% | |
76 Outperform | $145.58B | 117.16 | 24.28% | ― | 16.07% | ― | |
73 Outperform | $2.34B | 7.06 | 10.79% | 8.59% | 0.83% | 22.06% | |
65 Neutral | $30.69B | 8.56 | 9.85% | ― | -1.33% | 32.92% | |
64 Neutral | $2.63B | ― | -2.48% | 7.42% | -3.61% | -143.37% | |
61 Neutral | $41.26B | -0.79 | -14.19% | 3.78% | 2.39% | -73.52% | |
49 Neutral | $229.06M | ― | -6.76% | ― | -18.43% | -349.12% |